Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates

被引：174
|
作者：
Dalrymple, Annette
Wild, Edward J.
Joubert, Richard
Sathasivam, Kirupa
Bjorkqvist, Maria
Petersen, Asa
Jackson, Graham S.
Isaacs, Jeremy D.
Kristiansen, Mark
Bates, Gillian P.
Leavitt, Blair R.
Keir, Geoff
Ward, Malcolm
Tabrizi, Sarah J.
机构：
[1] Natl Hosp Neurol & Neurosurg, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England
[2] Proteome Sci PLC, Surrey, England
[3] Inst Neurol, Dept Neurodegenerat, London WC1N 3BG, England
[4] Kings Coll London, Guys Hosp, Sch Med, London WC2R 2LS, England
[5] Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden
[6] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada
[7] Natl Hosp Neurol & Neurosurg, Neuroimmunol Lab, London WC1N 3BG, England
来源：
JOURNAL OF PROTEOME RESEARCH | 2007年 / 6卷 / 07期
基金：
英国医学研究理事会; 英国惠康基金;
关键词：
Huntington's disease; plasma; neuroinflammation; proteomics; 2D electrophoresis; LC/MS/MS; MALDI-TOF; ELISA; biomarkers;
D O I：
10.1021/pr0700753
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Huntington's disease (HD) causes widespread CNS changes and systemic abnormalities including endocrine and immune dysfunction. HD biomarkers are needed to power clinical trials of potential treatments. We used multiplatform proteomic profiling to reveal plasma changes with HD progression. Proteins of interest were evaluated using immunoblotting and ELISA in plasma from 2 populations, CSF and R6/2 mice. The identified proteins demonstrate neuroinflammation in HD and warrant further investigation as possible biomarkers.
引用
收藏
页码：2833 / 2840
页数：8
相关论文
共 50 条
  • [21] Targeted biochemical profiling of brain from Huntington's disease patients reveals novel metabolic pathways of interest
    Graham, Stewart F.
    Pan, Xiaobei
    Yilmaz, Ali
    Macias, Shirin
    Robinson, Andrew
    Mann, David
    Green, Brian D.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (07): : 2430 - 2437
  • [22] A comprehensive glycome profiling of Huntington's disease transgenic mice
    Gizaw, Solomon T.
    Koda, Toshiaki
    Amano, Maho
    Kamimura, Keiko
    Ohashi, Tetsu
    Hinou, Hiroshi
    Nishimura, Shin-Ichiro
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2015, 1850 (09): : 1704 - 1718
  • [23] Tissue and plasma proteomic profiling indicates AHSG as a potential biomarker for ascending thoracic aortic aneurysms
    Rafailia Kazamia
    Anna Keravnou
    Areti Moushi
    Kleitos Sokratous
    Kyriaki Michailidou
    Kristia Yiangou
    Marinos Soteriou
    Stavroulla Xenophontos
    Marios A. Cariolou
    Evy Bashiardes
    BMC Cardiovascular Disorders, 23
  • [24] Calpain activation in Huntington's disease
    Gafni, J
    Ellerby, LM
    JOURNAL OF NEUROSCIENCE, 2002, 22 (12) : 4842 - 4849
  • [25] Tissue and plasma proteomic profiling indicates AHSG as a potential biomarker for ascending thoracic aortic aneurysms
    Kazamia, Rafailia
    Keravnou, Anna
    Moushi, Areti
    Sokratous, Kleitos
    Michailidou, Kyriaki
    Yiangou, Kristia
    Soteriou, Marinos
    Xenophontos, Stavroulla
    Cariolou, Marios A.
    Bashiardes, Evy
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [26] Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia
    Ehtewish, Hanan
    Mesleh, Areej
    Ponirakis, Georgios
    de la Fuente, Alberto
    Parray, Aijaz
    Bensmail, Ilham
    Abdesselem, Houari
    Ramadan, Marwan
    Khan, Shafi
    Chandran, Mani
    Ayadathil, Raheem
    Elsotouhy, Ahmed
    Own, Ahmed
    Al Hamad, Hanadi
    Abdelalim, Essam M.
    Decock, Julie
    Alajez, Nehad M.
    Albagha, Omar
    Thornalley, Paul J.
    Arredouani, Abdelilah
    Malik, Rayaz A.
    El-Agnaf, Omar M. A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [27] Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease
    Vasiliki Lygirou
    Agnieszka Latosinska
    Manousos Makridakis
    William Mullen
    Christian Delles
    Joost P. Schanstra
    Jerome Zoidakis
    Burkert Pieske
    Harald Mischak
    Antonia Vlahou
    Journal of Translational Medicine, 16
  • [28] Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort
    Westwood, Sarah
    Baird, Alison L.
    Anand, Sneha N.
    Nevado-Holgado, Alejo J.
    Kormilitzin, Andrey
    Shi, Liu
    Hye, Abdul
    Ashton, Nicholas J.
    Morgan, Angharad R.
    Bos, Isabelle
    Vos, Stephanie J. B.
    Baker, Susan
    Buckley, Noel J.
    Ten Kate, Mara
    Scheltens, Philip
    Teunissen, Charlotte E.
    Vandenberghe, Rik
    Gabel, Silvy
    Meersmans, Karen
    Engelborghs, Sebastiaan
    De Roeck, Ellen E.
    Sleegers, Kristel
    Frisoni, Giovanni B.
    Blin, Olivier
    Richardson, Jill C.
    Bordet, Regis
    Molinuevo, Jose L.
    Rami, Lorena
    Wallin, Anders
    Kettunen, Petronella
    Tsolaki, Magda
    Verhey, Frans
    Lleo, Alberto
    Sala, Isabel
    Popp, Julius
    Peyratout, Gwendoline
    Martinez-Lage, Pablo
    Tainta, Mikel
    Johannsen, Peter
    Freund-Levi, Yvonne
    Froelich, Lutz
    Dobricic, Valerija
    Legido-Quigley, Cristina
    Bertram, Lars
    Barkhof, Frederik
    Zetterberg, Henrik
    Morgan, B. Paul
    Streffer, Johannes
    Visser, Pieter Jelle
    Lovestone, Simon
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (01) : 213 - 225
  • [29] Gene Expression Changes in Blood as a Putative Biomarker for Huntington's Disease
    Lovrecic, Luca
    Kastrin, Andrej
    Kobal, Jan
    Pirtosek, Zvezdan
    Krainc, Dimitri
    Peterlin, Borut
    MOVEMENT DISORDERS, 2009, 24 (15) : 2277 - 2281
  • [30] Reflexive and voluntary saccadic eye movements as biomarker of Huntington's Disease
    Grabska, Natalia
    Wojcik-Pedziwiatr, Magdalena
    Slawek, Jaroslaw
    Soltan, Witold
    Gawryluk, Justyna
    Szczudlik, Andrzej
    Rudzinska-Bar, Monika
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2024, 58 (03) : 323 - 330
12345